Institutional investors purchased a net $2.2 million shares of GILD during the quarter ended June 2015 and now own 86.64% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 784.0 Thousand shares of Gilead Sciences
NUMERIC INVESTORS LLC Bought 501.2 Thousand shares of Gilead Sciences